文献速递妇科

针状内镜对交界性卵巢肿瘤的保守分期

Needleoscopic Conservative Staging of Borderline Ovarian Tumor.
PubMed 文献 · J Minim Invasive Gynecol · 2016-10-27

本文通过视频文章和文献综述(加拿大工作组分类III级)报告一例29岁女性右侧卵巢单房囊肿伴乳头状突起,行针状内镜保守分期手术(右卵巢囊肿切除、腹膜活检、结肠下网膜活检、腹膜细胞学),手术时间62分钟,估计出血量<10 mL,无术中并发症,术后次日出院,病理证实为浆液性交界性卵巢肿瘤,术后30天患者和术者美容满意度均为10/10。作者认为针状器械可能对附件良性或交界性疾病有益,目前仅应考虑混合手术设置以克服缺乏双极能量的不足,需进一步研究。

要点

  • 29岁女性右卵巢单房囊肿伴乳头状突起,行针状内镜保守分期手术。
  • 总手术时间62分钟,估计出血量<10 mL,无术中并发症,术后次日出院。
  • 病理证实为浆液性交界性卵巢肿瘤,术后30天美容满意度患者和术者均为10/10。

核心结论

  • 据作者所知,此前尚无针状内镜治疗交界性卵巢肿瘤的报道,这对超微创入路构成巨大挑战。
  • 基于初步经验,针状器械可能成为附件良性或交界性疾病的有益工具。
  • 目前仅应考虑混合手术设置以克服缺乏双极能量的不足。
  • 需进一步研究以明确这种新方法的获益、优势和成本。

研究设计与样本

  • 视频文章和文献综述(加拿大工作组分类III级)。
  • 一例29岁女性,术前磁共振成像和超声显示右侧卵巢单房囊肿伴乳头状突起,怀疑交界性卵巢肿瘤。
  • 患者根据当地法规签署了经腹或腹腔镜入路的知情同意书,并同意使用手术图像和视频。
  • 此类手术无需机构审查委员会批准。

主要发现

  • 治疗包括保守分期:右卵巢囊肿切除、腹膜活检、结肠下网膜活检和腹膜细胞学检查。
  • 器械包括两个2.4毫米针状内镜器械。
  • 总手术时间62分钟,估计出血量<10 mL。
  • 未记录到术中并发症。
  • 手术结束时切口外径仅增加至多3毫米,患者术后次日出院。

临床怎么用

  • 作者认为针状器械可能成为附件良性或交界性疾病的有益工具。
  • 作者认为目前仅应考虑混合手术设置以克服缺乏双极能量的不足。
  • 作者建议需进一步研究以明确这种新方法的获益、优势和成本。

局限性

  • 据作者所知,此前尚无针状内镜治疗交界性卵巢肿瘤的报道。
  • 目前仅应考虑混合手术设置以克服缺乏双极能量的不足。
  • 需进一步研究以明确这种新方法的获益、优势和成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To investigate the safety and technical feasibility of needleoscopic fertility-sparing staging of borderline ovarian tumors. DESIGN: Video article and review of the literature (Canadian Task Force classification Level III). SETTING: This 29-year-old woman had a right ovarian cyst suspicious for borderline ovarian tumor on preoperative magnetic resonance imaging and ultrasound showing the presence of a right unilocular ovarian cyst with a papillary projection. Informed consent for abdominal or laparoscopic approach was obtained from the patient in accordance with the local legislation. The patient also provided informed consent to use images and videos of the procedure. Institutional Review Board approval was not required for this kind of procedure. INTERVENTIONS: Treatment involved conservative staging with right ovarian cystectomy, peritoneal biopsies, infracolic omental biopsy, and peritoneal cytology. Instrumentation included two 2.4-mm needleoscopic instruments. The total operative time was 62 minutes, and estimated blood loss was <10 mL. No intraoperative complications were recorded. At the end of the surgical procedure, the outer diameter of the incision was increased by only up to 3 mm. The patient was discharged the day after the procedure. Histopathological analysis confirmed a serous borderline ovarian tumor. A 30 days postoperative follow-up, a satisfactory cosmetic result was reported by both the patient (score of 10 of out of a possible 10) and the surgeon (10 of 10). CONCLUSION: To the best of our knowledge, there are no previously published reports of needleoscopic treatment of borderline ovarian tumor, which represents a great challenge for ultra-minimally invasive approaches [1-3]. Based on our initial experience, the needleoscopic instruments could prove to be a beneficial tool in adnexal benign or borderline disease. At present, only a hybrid operative setting should be considered to overcome the lack of bipolar energy [4-6]. Further studies are needed to define the benefits, advantages, and costs of this novel approach.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Gueli Alletti S, Rossitto C, Perrone E, et al. Needleoscopic Conservative Staging of Borderline Ovarian Tumor. J Minim Invasive Gynecol. 2016. PMID: 27989810. doi:10.1016/j.jmig.2016.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。